A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome)

Author:

Guo Lijun,Yuan Hui,Zhang Dawu,Zhang Jian,Hua Qi,Ma Xiaochang,Chen Keji

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference20 articles.

1. Chinese guidelines for the diagnosis and management of heart failure 2018;Chin J Cardiol,2018

2. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China heart failure (China-HF) Registry;Zhang;J Card Fail,2017

3. Heart failure: preventing disease and death worldwide;Ponikowski;Esc Heart Failure,2015

4. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure;Ponikowski;Eur J Heart Fail,2016

5. Expert consensus on diagnosis and treatment of integrated traditional and western medicine in chronic heart failure;Chin J Integr Tradit West Med,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3